At Courtagen, we offer DNA testing that uses next generation sequencing to diagnose neurological, mitochondrial, and other disorders. Because the brain and mitochondria are so complex, many of our panels have a thousand genes or more.
After performing diagnostic testing on several thousand patients with seizure disorders, Courtagen's Clinical Team has described a variant in the ALG13 gene that directly causes infantile spasms, intellectual disability, and severe neurologic disease.
Earlier this week, voters in four states (Arkansas, Florida, Montana, and North Dakota) approved legislation that made medicinal marijuana legal in their respective states. Now more than half the states have approved medical marijuana in some form. It’s fitting that this landmark was reached in the month of November, which happens to be Epilepsy Awareness month.
Last week we packed up our computers, sequencers, pipettes, and numerous test tubes filled with saliva to move down the road to our new headquarters at 8 Cabot Road Woburn, MA.
Topics: Company News
As with computers and other technology-based fields, an incredible amount of progress has been made in our understanding of genetics since Watson and Crick first described DNA over 60 years ago.
Next generation sequencing is a relatively new lab method that looks at more genes in less time than previous technologies, precipitating an explosion of knowledge connecting genes and health. Advances are also being made in the treatment and management of genetic conditions.
Even with all this advancement, there are some myths about genetic testing that still exist. Today we are going to debunk four of the most commonly-believed genetic testing myths.
Topics: Genetic Testing
Mitochondrial disease is typically understood by healthcare providers as a disease of severe neuromuscular manifestations and brain abnormalities, or recognized as various syndromes. However, mitochondrial disease is complicated to diagnose and difficult for many clinicians to understand or accept for the following reasons:
Courtagen is excited to announce that it has partnered with the United Mitochondrial Disease Foundation as part of a new pilot program designed to expand access to genetic testing for patients with mitochondrial disorders who have been unable to access testing due to financial barriers.
Topics: Courtagen Gives Back
Maybe your physician has ordered genetic testing for you, or perhaps you’ve been wondering if it might be helpful to have your child undergo a genetic test. Perhaps you are a physician who has never used genetic testing as a diagnostic tool before. If you are considering a genetic test for any reason, but aren’t sure if it’s something you want to pursue, this article is for you.